News


All News

When Carol Isaacs, M.D., was a dermatology resident, she started collecting what she calls "dermabilia" - "nothing particularly valuable, but nevertheless, interesting to me," says the board-certified dermatologist who is in private practice and on staff at St. Helena Hospital.

A patient with a complicated chronic skin disease consulted me some time ago. He had been under the care of another practitioner and was very satisfied with the quality of the care he had been receiving, but he could no longer afford the treatments being prescribed.

Hungarian-born dermatologist Judith Hellman, M.D., has a life rich in experiences. She served in the Israeli Air Force; she's a classically trained violinist and jazz pianist; and, ultimately, she trained in medicine to follow the footsteps of her father, the late Lawrence Hellman, M.D. - formerly on the dermatologic faculty of Mount Sinai School of Medicine, New York - and her mother, Vera Rados, M.D., an allergist/immunologist, who continues

Next to biopsies and the destruction of premalignant lesions, the third most common bread-and-butter service for dermatologists is the destruction of benign lesions (CPT codes 17110 and 17111). In this article, we will discuss the proper use of these codes, rules that govern their use and bundling issues

Despite urging from President Obama, both houses of Congress went home for their August break without passing any version of healthcare reform. All facets of reform appear to be on the table still, while the proposals being considered have a multitude of interpretations.

Ft. Myers, Fla. - NeoGenomics, a provider of cancer genetics testing services, announced that it has entered into a Strategic Supply Agreement with Abbott. The agreement provides for Abbott to supply materials for NeoGenomics to develop its own FISH (fluorescence in situ hybridization)-based test for the diagnosis of melanoma.

Sheffield, England - New research data demonstrates that mild, moderate and potent strengths of topical corticosteroids (TCS) cause a thinning of the stratum corneum, particularly when applied for longer periods of time, whereas topical calcineurin inhibitors show no negative change in the integrity of the skin barrier.

A clinical trial evaluating neck rejuvenation using an ablative fractional CO2 laser showed all patients (n = 13) achieved at least 25 percent improvement in rhytids, crepe-like skin, neck tightness, and pigmentation. There were no problems with scarring or pigmentary changes.

Las Vegas - Although some recent animal research and human case reports have spurred concerns regarding the safety of Botox Cosmetic (botulinum toxin A, Allergan), one of the product's pioneers says that Botox remains safe when used as directed for cosmetic indications.

Botulinum toxin type A (Botox Allergan) is the gold standard to treat axillary hyperhidrosis, but it also can be administered to treat palmar hyperhidrosis or plantar hyperhidrosis. In very rare instances, it can be used to treat the mid-face. There is not a standard dosing schedule in using botulinum toxin type A to treat hyperhidrosis.